If you believe that Type 1 Diabetes patients could benefit from additional quality treatment options, join the GLITTER 1 Research Study evaluating the investigational Gan & Lee insulin glargine.

 

To pre-qualify for this study, you must:

• Be 18 to 75 years of age

• Have been diagnosed with Type 1 Diabetes

• Be taking a short-acting and long-acting insulin medication that your doctor prescribed for at least 6 months

All study-related visits, tests, and drugs will be provided at no cost to you.